Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson’s disease. The US FDA this week approved the sale of the treatment, which harnesses innovative technology to make managing the condition easier and more impactful, will be available towards the end of 2025.
Category: Medical Devices, Medical Innovations, Body & Mind
Tags: Parkinson’s Disease, FDA, Drug delivery, Neuroscience, Age-Related, Medication, Biotechnology
